Fetal safety of erythromycin. An update of Swedish data.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

In previous studies from the Swedish Medical Birth Register, a possible association between erythromycin therapy and an increased risk for cardiovascular defects was found. Other studies using different methodology have not verified this observation. The finding resulted in a warning for the use of erythromycin in early pregnancy, followed by a marked decline in such use. The present study was conducted to follow up on the previous observations and to find methodological explanations for the variation in results in these different published studies.

Detaljer

Författare
  • Bengt Källén
  • Bengt R Danielsson
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Reproduktionsmedicin och gynekologi
Originalspråkengelska
Sidor (från-till)355-360
TidskriftEuropean Journal of Clinical Pharmacology
Volym70
Utgåva nummer3
StatusPublished - 2014
PublikationskategoriForskning
Peer review utfördJa